Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 55.33B | 44.74B | 49.34B | 53.95B | 39.11B | 33.15B |
Gross Profit | 27.03B | 23.88B | 23.30B | 20.20B | 17.06B | 16.14B |
EBITDA | 20.55B | 15.46B | 13.92B | 12.77B | 11.80B | 10.12B |
Net Income | 5.04B | 5.61B | 4.80B | 4.34B | 3.88B | 3.61B |
Balance Sheet | ||||||
Total Assets | 157.57B | 158.29B | 150.03B | 154.67B | 141.75B | 122.52B |
Cash, Cash Equivalents and Short-Term Investments | 3.34B | 4.57B | 5.47B | 7.47B | 8.40B | 4.61B |
Total Debt | 56.38B | 57.73B | 61.65B | 50.42B | 44.27B | 40.51B |
Total Liabilities | 98.15B | 97.24B | 89.74B | 96.55B | 85.63B | 75.30B |
Stockholders Equity | 53.88B | 47.13B | 43.11B | 41.12B | 40.48B | 35.41B |
Cash Flow | ||||||
Free Cash Flow | 2.48B | 3.72B | 4.41B | 3.66B | 1.19B | 2.50B |
Operating Cash Flow | 6.62B | 11.93B | 12.13B | 10.44B | 8.11B | 8.35B |
Investing Cash Flow | -6.01B | -8.40B | -9.07B | -10.15B | -9.49B | -6.64B |
Financing Cash Flow | -2.21B | -2.27B | -2.35B | 151.00M | 1.87B | -71.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | €7.94B | 10.62 | 13.06% | 1.80% | 2.05% | 307.60% | |
70 Outperform | €23.25B | 12.74 | 22.84% | 6.38% | 2.66% | 1.26% | |
68 Neutral | €31.00B | 14.54 | 26.86% | 4.48% | -4.53% | 221.40% | |
67 Neutral | €112.71B | 20.93 | 10.92% | 3.11% | -1.89% | -21.48% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
59 Neutral | €9.08B | 24.69 | 10.14% | 3.85% | -23.15% | -39.13% | |
55 Neutral | €3.63B | 26.82 | 5.64% | 7.13% | 2.37% | ― |